Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Jul 15, 2021; 13(7): 716-731
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.716
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.716
Figure 6 Survival and recurrence-free survival of hepatocellular carcinoma patients with protein phosphatase 2 regulatory subunit B''α low expression or meeting Milan criteria.
A: Overall survival rate, it could be seen from Figure A that the survival rate of the two groups of patients with low expression of protein phosphatase 2 regulatory subunit B''α were different from those of patients who met the Milan criteria (P < 0.05); B: Recurrence-free survival rate, the same result was observed in recurrence-free survival (P < 0.05). PPP2R3A: Protein phosphatase 2 regulatory subunit B''α.
- Citation: He JJ, Shang L, Yu QW, Jiao N, Qiu S, Zhu WX, Wu DF, Tian YE, Zhang Q. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World J Gastrointest Oncol 2021; 13(7): 716-731
- URL: https://www.wjgnet.com/1948-5204/full/v13/i7/716.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i7.716